http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021233571-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5622efed23b5abfbc1b385574151480
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2021-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_422bf4a5977a9f466f2baf5c16cdc0b6
publicationDate 2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021233571-A1
titleOfInvention Treatment agent for antiviral therapy, applicator, and method for producing a treatment agent
abstract The invention relates to a treatment agent for the antiviral therapy of external herpes simplex diseases, in particular herpes simplex labialis, and to a method for producing same which reduces the occurrence of side effects and/or interactions with a low degree of development complexity and which allows an application by the patient with an at least minimal level of pain. This is achieved in that the treatment agent consists of a topically applicable carrier material which, as a transdermally active antiviral drug, is provided solely with a local anesthetic.
priorityDate 2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2061432-B9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006030073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012004669-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015374704-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017212422-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4499084-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449288622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914

Total number of triples: 42.